The HCV Treatment Cascade: Race Is a Factor to Consider.
作者信息
Balakrishnan Maya, Kanwal Fasiha
机构信息
Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Department of Medicine, Houston VA HSR&D Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
出版信息
J Gen Intern Med. 2019 Oct;34(10):1949-1951. doi: 10.1007/s11606-019-04962-3.
Abstract
摘要
相似文献
1
The HCV Treatment Cascade: Race Is a Factor to Consider.
J Gen Intern Med. 2019 Oct;34(10):1949-1951. doi: 10.1007/s11606-019-04962-3.
2
Universal screening for chronic hepatitis C virus.
Liver Int. 2016 Jan;36 Suppl 1:62-6. doi: 10.1111/liv.13012.
3
Strategies to manage hepatitis C virus (HCV) infection disease burden - volume 2.
J Viral Hepat. 2015 Jan;22 Suppl 1:46-73. doi: 10.1111/jvh.12352.
4
The influence of race and language on chronic hepatitis C virus infection management.
Eur J Gastroenterol Hepatol. 2009 Feb;21(2):131-6. doi: 10.1097/MEG.0b013e32830b387b.
5
Real life experiences in HCV management in 2018.
Expert Rev Anti Infect Ther. 2019 Feb;17(2):117-128. doi: 10.1080/14787210.2019.1563755. Epub 2019 Jan 15.
6
American Gastroenterological Association technical review on the management of hepatitis C.
Gastroenterology. 2006 Jan;130(1):231-64; quiz 214-7. doi: 10.1053/j.gastro.2005.11.010.
7
Expanded hepatitis C virus screening recommendations promote opportunities for care and cure.
Ann Intern Med. 2013 Sep 3;159(5):364-5. doi: 10.7326/0003-4819-159-5-201309030-00675.
8
[Screening and diagnosis of hepatitis B and C].
Rev Prat. 2005 Mar 31;55(6):615-23.
9
Treatment of chronic Hepatitis C: a smart coat over a ragged dress?
Dig Liver Dis. 2009 Jul;41(7):465-6. doi: 10.1016/j.dld.2009.04.001. Epub 2009 May 1.
10
Should you be tested for hepatitis C? New treatments promise high cure rates with fewer side effects. But carefully consider the pros and cons of testing.
Harv Mens Health Watch. 2012 Sep;17(2):6.
引用本文的文献
1
Stages of care for patients with chronic hepatitis C at a hospital in southern Brazil.
World J Hepatol. 2023 Aug 27;15(8):973-984. doi: 10.4254/wjh.v15.i8.973.
2
Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era.
Clin Gastroenterol Hepatol. 2023 Aug;21(9):2288-2297.e4. doi: 10.1016/j.cgh.2022.11.038. Epub 2022 Dec 12.
3
Comment on review article: Chronic hepatitis C virus infection cascade of care in pediatric patients.
World J Gastroenterol. 2022 Apr 14;28(14):1494-1498. doi: 10.3748/wjg.v28.i14.1494.
4
Sustained Impact of the Coronavirus Disease 2019 Pandemic on Hepatitis C Virus Treatment Initiations in the United States.
Clin Infect Dis. 2022 Aug 24;75(1):e955-e961. doi: 10.1093/cid/ciac175.
本文引用的文献
1
Significant Increase in Risk of Fibrosis or Cirrhosis at Time of HCV Diagnosis for Hispanics With Diabetes and Obesity Compared With Other Ethnic Groups.
Clin Gastroenterol Hepatol. 2019 Jun;17(7):1356-1363. doi: 10.1016/j.cgh.2018.11.059. Epub 2018 Dec 6.
2
Race and Hepatitis C Care Continuum in an Underserved Birth Cohort.
J Gen Intern Med. 2019 Oct;34(10):2005-2013. doi: 10.1007/s11606-018-4649-6. Epub 2018 Sep 20.
3
Hepatitis C care cascade among persons born 1945-1965: 3 medical centers.
Am J Manag Care. 2018 Sep;24(9):421-427.
4
Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens.
Clin Gastroenterol Hepatol. 2019 Apr;17(5):930-939.e9. doi: 10.1016/j.cgh.2018.08.080. Epub 2018 Sep 8.
5
Disparities in hepatitis C virus infection screening among Baby Boomers in the United States.
Am J Infect Control. 2018 Dec;46(12):1341-1347. doi: 10.1016/j.ajic.2018.06.008. Epub 2018 Jul 14.
6
Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013-2015.
Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):503-513. doi: 10.1158/1055-9965.EPI-17-0855. Epub 2018 Mar 27.
7
Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA.
Aliment Pharmacol Ther. 2018 Apr;47(7):1023-1031. doi: 10.1111/apt.14527. Epub 2018 Jan 29.
8
Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents.
Aliment Pharmacol Ther. 2017 Nov;46(10):992-1000. doi: 10.1111/apt.14328. Epub 2017 Sep 26.
9
Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease.
Hepatology. 2019 Feb;69(2):487-497. doi: 10.1002/hep.29408. Epub 2018 May 15.
10
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents.
Gastroenterology. 2017 Oct;153(4):996-1005.e1. doi: 10.1053/j.gastro.2017.06.012. Epub 2017 Jun 19.
Zotero 插件